【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Fatty Liver Disease Overview 10
Therapeutics Development 11
Pipeline Products for Fatty Liver Disease – Overview 11
Pipeline Products for Fatty Liver Disease – Comparative Analysis 12
Fatty Liver Disease – Therapeutics under Development by Companies 13
Fatty Liver Disease – Therapeutics under Investigation by Universities/Institutes 16
Fatty Liver Disease – Pipeline Products Glance 17
Late Stage Products 17
Clinical Stage Products 18
Early Stage Products 19
Unknown Stage Products 20
Fatty Liver Disease – Products under Development by Companies 21
Fatty Liver Disease – Products under Investigation by Universities/Institutes 23
Fatty Liver Disease – Companies Involved in Therapeutics Development 24
ACROVIS biostructures GmbH 24
ChemoCentryx, Inc. 25
Conatus Pharmaceuticals Inc. 26
Daewoong Pharmaceutical Co., Ltd. 27
Dr. Falk Pharma GmbH 28
DURECT Corporation 29
Galmed International Ltd. 30
Generon (Shanghai) Corporation Ltd. 31
Genovate Biotechnology Co., LTD. 32
Gilead Sciences, Inc. 33
Huons Co., Ltd. 34
Kyorin Pharmaceutical Co., Ltd. 35
Metabolic Solutions Development Company, LLC 36
Novartis AG 37
Protalix BioTherapeutics, Inc. 38
Raptor Pharmaceuticals Corp. 39
TCM Biotech International Corp 40
Tobira Therapeutics, Inc. 41
Verva Pharmaceuticals Limited 42
Zafgen Inc. 43
Fatty Liver Disease – Therapeutics Assessment 44
Assessment by Monotherapy Products 44
Assessment by Target 45
Assessment by Mechanism of Action 48
Assessment by Route of Administration 50
Assessment by Molecule Type 51
Drug Profiles 53
ACR-488 – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
Aramchol – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
CCX-872 – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
cenicriviroc mesylate – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
CSN-501 – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
cysteamine DR – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
Drugs to Inhibit ABHD6 for Gastrointestinal and Metabolic Disorders – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
DV-928 – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
DWP-10292 – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
emricasan – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
etanercept biosimilar – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
F-652 – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
HU-002 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
MAT-8800 – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
MB-12066 – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
methazolamide – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
MN-002 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
MSDC-0602 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
norursodeoxycholic acid – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
oltipraz – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
PCBB-7 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
pradigastat sodium – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
Px-102 – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
Px-103 – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
Px-104 – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
Recombinant Protein for Atherosclerosis and Hepatic Steatosis – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
Small Molecule to Inhibit IKK and TBK1 for Cardiovascular, Gastrointestinal and Metabolic Disorders – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
Small Molecule to Inhibit Them1 for Metabolic, Immunology and Gastrointestinal Diseases – Drug Profile 87
Product Description 87
Mechanism of Action 87
R&D Progress 87
Small Molecules to Activate AMPK for Fatty Liver Disease – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
SR-9238 – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
Synthetic Peptide for Cardiovascular, Gastrointestinal and Metabolic Disorders – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
TCM-606F – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
VVP-100-X – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
ZGN-839 – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
Fatty Liver Disease – Recent Pipeline Updates 95
Fatty Liver Disease – Dormant Projects 112
Fatty Liver Disease – Product Development Milestones 114
Featured News & Press Releases 114
Jan 12, 2015: Researchers uncover more clues to how drug reverses obesity, diabetes, fatty liver disease 114
Jul 22, 2014: Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 115
Apr 28, 2014: Galmed Pharmaceuticals Commences Patient Screening for Aramchol Pharmacokinetic and Food Effect Studies 116
Mar 03, 2014: Conatus Pharmaceuticals Extends Liver Disease Reach With Phase 2 NAFLD/NASH Trial 116
Dec 19, 2012: Scripps Florida Scientists Develop New Compound that Reverses Fatty Liver Disease 117
Oct 31, 2012: Phenex Pharma Completes Phase I Studies With FXR-Agonist Px-102 118
Oct 06, 2011: Metabolic Solutions Development Company Receives $1.1m NIH Grant To Further Investigate MSDC-0602 For Treatment Of Fatty Liver Disease 119
Oct 14, 2010: Galmed Initiates Phase II Clinical Trial Of Aramchol For Treatment Of Fatty Liver Disease 119
Sep 21, 2008: Galmed Medical Research Initiates Its Phase I study Of Aramchol, Its Drug Candidate For Fatty Liver Disease 120
Appendix 122
Methodology 122
Coverage 122
Secondary Research 122
Primary Research 122
Expert Panel Validation 122
Contact Us 122
Disclaimer 123
【レポート販売概要】
■ タイトル：脂肪性肝疾患(Fatty Liver Disease)：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Fatty Liver Disease - Pipeline Review, H1 2015
■ 発行日：2015年3月11日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6261IDB
■ 調査対象地域：グローバル
- 世界の分散制御システム(DCS)市場動向（2012-2016）TechNavio's analysts forecast the Global Distributed Control System (DCS) market to grow at a CAGR of 3.35 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for DCS solutions in the Power industry. The Global DCS market has also been witnessing the development of integrated solutions. However, the declining price of DCS solutions …
- デジタル新聞発行の世界市場2015-2019About Digital Newspaper Publishing Publishing involves the development, acquisition, copy editing, design, production, marketing, and distribution of content through both physical and electronic media. Newspaper publishing includes news gathering, writing columns, advertisements, printing, selling, and distribution. This can be in a digital form or a print form. Newspapers can be digitally publish …
- 食品・飲料用金属缶の世界市場：アルミ缶/スチール缶The global food & beverage metal cans market is marked with intense competition due to the presence of large number of big and small firms in the metal can manufacturing industry. This segment includes the growth strategies adopted by the market players between 2011 and 2014 to expand their market share. Expansions & investments, acquisitions, new product & technology launches, agreements, collabo …
- 世界主要国における淋疾検査市場2015The report presents a detailed analysis of the Gonorrhea diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Gonorrhea definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Com …
- 世界における小型自動車用計器類及びコックピット市場（2008-2028）This latest just-auto report edition offers a global review of the OE cockpits and instrumentation sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE cockpits and instrumentation market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players incl …
- 世界の美容機器開発動向：医療機器パイプライン分析2015Aesthetic Devices - Medical Devices Pipeline Assessment, 2015 Summary GlobalData's Medical Devices sector report, “Aesthetic Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Aesthetic Devices currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The …
- トラクターインプルメントの世界市場予測（～2023年）“The tractor implements market is projected to grow at a CAGR of 5.84% from 2018 to 2023.”The tractor implements market is projected to reach USD 76.1 billion by 2023, from USD 57.3 billion in 2018, at a CAGR of 5.84%. The tractor implements market is driven by various factors such as limited farm labor, government subsidies for usage of farm equipment, and increasing trend of mechanization in agr …
- 歯科インプラントおよび補綴の世界市場：クラウン、ブリッジ、義歯、アバットメントDental implants, also known as endosseous fixtures, are substitutes for missing teeth that are placed into the jaw to support restorations. Dental implants provide a strong foundation and are an ideal option for people who have lost a tooth due to periodontal disease, an injury, or some other reason. Prosthetics dentistry involves the diagnosis and treatment of infected teeth as well as the recons …
- 股関節置換：グローバル市場分析と予測MediPoint: Total Hip Replacement - Global Analysis and Market Forecasts Summary Osteoarthritis has become a global public health concern with no cure. It is the most common form of arthritis that is primarily due to wear and tear of the joints. With the aging global population, this is an indication that is growing rapidly with the hip being one of the most common joints afflicted. While the prima …
- アトピー性皮膚炎治療薬の世界市場予測および分析（～2024）PharmaPoint: Atopic Dermatitis - Global Drug Forecast and Market Analysis to 2024 Summary Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for others to follow suit. By the mid-to-late term of GlobalData’s 201 …
- 段ボール箱の米国市場2017-2021ABSTRACTAbout Corrugated Box Corrugated boxes are paper-based containers used in packaging durable and non-durable goods. These boxes are flexible, durable, and lightweight, and are used as a cost-effective form of packaging. Corrugated boxes are used for packaging consumer and industrial goods. These boxes are not only used as shipping containers but are also used as retail-ready packaging boxes …
- 世界のバイク用ライト市場2015The Global Motorcycle Lighting Industry Report 2015 is a professional and in-depth study on the current state of the Motorcycle Lighting industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Motorcycle Lighting market analysis is provided for the international markets including development trends, compe …
- 人工手関節全置換術：グローバル市場分析と予測MediPoint: Total Wrist Reconstruction - Global Analysis and Market Forecasts Summary Wrist arthritis is a serious issue that affects a significant number of people and making it difficult to engage in many day to day activities. While it is most prevalent in the developed nations, it is a growing concern in the emerging markets as well. The primary indications that have caused wrist arthritis are …
- 循環腫瘍細胞（CTC）の世界市場：技術別（CTC濃縮法、CTC検出法、CTC分析）、用途別（がん細胞研究、EMTバイオマーカー開発、腫瘍形成研究）、地域別予測Global Circulating Tumor Cells (CTC) Market to reach USD 22.5 billion by 2025. Global Circulating Tumor Cells (CTC) Market valued approximately USD 5 billion in 2016 is anticipated to grow with a healthy growth rate of more than 18.20% over the forecast period 2017-2025. Circulating tumor cells are significantly useful in determining the status of disease progression rate and projection of therapy …
- 輸送・流通分野におけるRTLSの世界市場2016-2020：RFID、Wi-Fi、バーコード、QRコードAbout RTLS RTLS is the technology used to find, track, manage, and identify the geographical position of a target on a real-time basis with the help of nodes/tags and readers. Nodes or tags are embedded in smartphones or navigational devices, through which a user can easily track an object. A reader is used to receive wireless signals from the tags, through which an object can be located. RTLS wor …
